The Clinical Efficacy of Midline Catheters

NCT03457259 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-04-07

No results posted yet for this study

Summary

The study will evaluate the clinical efficacy of midline catheters compared to conventional treatment in patients with an expected intravenous therapy duration of more than 5 days. Patients will be randomized in a 1:1 ratio. The study will include 120 patient. Endpoints include insertion of CVSs, peripheral venous catheters, catheter patency and a number of possible complications.

Conditions

  • Intravenous Catheters

Interventions

DEVICE

PVC and/or PICCline

Pt. will receive PVC and/or PICCline

DEVICE

Midline

Pt. will receive midline

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Emma Bundgaard, MS · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-12
Primary Completion
2019-07-30
Completion
2019-07-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03457259 on ClinicalTrials.gov